Drug maker, AstraZeneca briefs Nigeria on fears of COVID-19 vaccine

A brief from AstraZeneca group has been received the Nigerian government on fears of the COVID-19 vaccines.

At the Presidential Task Force (PTF) on COVID-19, Abdullazzi Abdullahi, Permanent Secretary, Ministry of Health, said the company provided satisfactory clarification.

The Permanent Secretary disclosed that the government got reassurance of the safety and efficacy of the vaccine already distributed to states.

“We have not yet recorded unusual side effects among those who have received the vaccine which include myself. NAFDAC is monitoring the process as part of a global tracking of adverse effects of the vaccine.

“Anyone who has received the vaccine and is experiencing any adverse reaction should please report to NAFDAC using the Med Safety App on your phone or report at the centre where you received the jab.”

Recall that the country received 3.94 million doses of AstraZeneca COVID-19 vaccines, manufactured by the Serum Institute of India(SII) and shipped to Nigeria via the COVAX facility.

ALSO READ: NGF reacts to assassination attempt on Gov Ortom

Abdullahi said that the total number of confirmed cases in Nigeria as of Monday morning was 161,737 from 1,727,467 samples, with a test positivity rate of 9.4 per cent.

He added that Nigeria had recorded 2,030 deaths since the outbreak on February 27, 2020.

Related Articles

Popular Articles